Posttranslational modification of Aurora A‐NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma-Reference-Cited by-同舟云学术

Posttranslational modification of Aurora A‐NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma

Published:2022-04 Issue:4 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Jiang Hongmei¹,Wang Yixuan¹,Wang Jingjing¹,Wang Yafei²,Wang Sheng¹,He Enyang¹,Guo Jing²,Xie Ying¹,Wang Jingya¹,Li Xin¹,Peng Ziyi¹,Wang Mengqi¹,Hou Jian³,Liu Zhiqiang¹²^ORCID

Affiliation:

1. The Province and Ministry Co‐sponsored Collaborative Innovation Center for Medical EpigeneticsTianjin Key Laboratory of Cellular Homeostasis and Human DiseasesDepartment of Physiology and PathophysiologySchool of Basic Medical ScienceTianjin Medical UniversityTianjinChina

2. Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Tianjin Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Tianjin China

3. Department of Hematology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

Funder

National Natural Science Foundation of China

Tianjin Research Innovation Project for Postgraduate Students

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.744

Reference44 articles.

1. Multiple Myeloma: Molecular Pathogenesis and Disease Evolution

2. Relapsed/Refractory Multiple Myeloma in 2020/2021 and Beyond

3. Clinical experience of CAR T cells for multiple myeloma

4. Roadmap to cure multiple myeloma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NSD family proteins: Rising stars as therapeutic targets;Cell Insight;2024-04

2. Epigenetic Alterations as Vital Aspects of Bortezomib Molecular Action;Cancers;2023-12-23

3. A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma;Frontiers in Cell and Developmental Biology;2023-06-02